A Meta-Analysis of Interleukin-10 -592 Promoter Polymorphism Associated with Gastric Cancer Risk

We aimed to explore the role of IL-10 -592 A/C SNP in the susceptibility to gastric cancer through a systematic review and meta-analysis. Each initially included article was scored for quality appraisal. 17 studies were eligible for the meta-analysis. We adopted the most probably appropriate genetic model (recessive model). Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication biases were estimated. IL-10-592 AA genotype is associated with the reduced risk of developing gastric cancer among Asians and even apparently observed among Asians high quality subgroup, suggesting IL-10-592 AA genotype may seem to be more protective from overall gastric cancer in Asian populations. IL-10-592 AA genotype is also associated with the overall reduced gastric cancer susceptibility in persons with H. pylori infection compared with controls without H. pylori infection, suggesting IL-10-592 AA genotype may seem to be more protective from overall gastric cancer susceptibility in persons infected with H. pylori. IL-10-592 AA genotype is not associated with either pathologic subtypes (intestinal or diffuse) or anatomic subtypes (non-cardia or cardia) of gastric cancer susceptibility. Genotyping methods like direct sequencing should be highly advocated to be conducted in future well-designed high quality studies among different ethnicities or populations.

[1]  Bin Liu,et al.  : Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and , 2010 .

[2]  Gang Huang,et al.  Interleukin-10-819 promoter polymorphism in association with gastric cancer risk , 2012, BMC Cancer.

[3]  R. Zhou,et al.  −251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case–control studies , 2012, Molecular Biology Reports.

[4]  Xianze Meng,et al.  Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells , 2012, Medical Oncology.

[5]  Z. Wang,et al.  A Meta-Analysis of Interleukin-8 -251 Promoter Polymorphism Associated with Gastric Cancer Risk , 2012, PloS one.

[6]  Yun Cui,et al.  A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk. , 2011, DNA and cell biology.

[7]  G. Launoy,et al.  Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010 , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[8]  V. Valenti,et al.  Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy , 2011, Journal of surgical oncology.

[9]  H. Lenz,et al.  Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models , 2011, International journal of cancer.

[10]  B. Song,et al.  Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. , 2011, World journal of gastroenterology.

[11]  Jing Wang,et al.  The association between interleukin-10-592 polymorphism and gastric cancer risk: a meta-analysis , 2011, Medical oncology.

[12]  Peihua Ni,et al.  X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. , 2011, American journal of epidemiology.

[13]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[14]  Gang Huang,et al.  Interleukin‐1B and interleukin‐1 RN polymorphisms and gastric carcinoma risk: A meta‐analysis , 2010, Journal of gastroenterology and hepatology.

[15]  Bin Liu,et al.  Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 , 2010, Nature Genetics.

[16]  H. Jung,et al.  The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans. , 2010, Cytokine.

[17]  N. Hu,et al.  A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma , 2010, Nature Genetics.

[18]  Jing Wang,et al.  Polymorphism of IL-8 in 251 Allele and Gastric Cancer Susceptibility: A Meta-Analysis , 2010, Digestive Diseases and Sciences.

[19]  Liu Liu,et al.  Interleukin-8 -251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies. , 2010, Cytokine.

[20]  Tai-xiang Wu,et al.  Interleukin10 -592 Promoter Polymorphism Associated with Gastric Cancer Among Asians: A Meta-Analysis of Epidemiologic Studies , 2010, Digestive Diseases and Sciences.

[21]  Weibo Liang,et al.  IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. , 2010, European journal of cancer.

[22]  Weiwei Niu,et al.  Interleukin-8-251A/T polymorphism and Helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China , 2010, Molecular Biology Reports.

[23]  C. Peng,et al.  Interleukin-10-819 Promoter Polymorphism Associated with Gastric Cancer among Asians , 2010, The Journal of international medical research.

[24]  L. Xiaobo,et al.  Association of interleukin-8 gene polymorphism with cachexia from patients with gastric cancer. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[25]  Shu-Chen Wang,et al.  Association of Interleukin-8 with Cachexia from Patients with Low-Third Gastric Cancer , 2009, Comparative and functional genomics.

[26]  B. Xia,et al.  [Association of IL-10 gene polymorphisms with gastroduodenal diseases in Hubei Han population]. , 2009, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[27]  D. Kang,et al.  Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. , 2009, The Journal of nutrition.

[28]  Nayoung Kim,et al.  The Effects of Genetic Polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced Gastroduodenal Diseases in Korea , 2009, Journal of clinical gastroenterology.

[29]  J. S. Kim,et al.  The Interleukin-8–251 A Allele is Associated With Increased Risk of Noncardia Gastric Adenocarcinoma in Helicobacter pylori-infected Koreans , 2009, Journal of clinical gastroenterology.

[30]  Sushovan Guha,et al.  CXCL8/IL‐8 and CXCL12/SDF‐1α co‐operatively promote invasiveness and angiogenesis in pancreatic cancer , 2009 .

[31]  N. Yasuda,et al.  Role of bacterial and genetic factors in gastric cancer in Costa Rica. , 2009, World journal of gastroenterology.

[32]  D. Fan,et al.  Molecular basis of therapeutic approaches to gastric cancer , 2009, Journal of gastroenterology and hepatology.

[33]  F. Clavel-Chapelon,et al.  Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  Tai-xiang Wu,et al.  Interleukin-10 -1082 promoter polymorphism associated with gastric cancer among Asians. , 2008, European journal of cancer.

[35]  J. Thompson,et al.  How should we use information about HWE in the meta-analyses of genetic association studies? , 2008, International journal of epidemiology.

[36]  F. Canzian,et al.  The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[37]  Á. Lanas,et al.  Gastric Cancer Susceptibility Is Not Linked to Pro-and Anti-Inflammatory Cytokine Gene Polymorphisms in Whites: A Nationwide Multicenter Study in Spain , 2007, The American Journal of Gastroenterology.

[38]  H. Sugimura,et al.  Effects of interleukin‐10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects , 2007, Journal of gastroenterology and hepatology.

[39]  Jing Shen,et al.  [Meta-analysis on the relationship between IL8-251 gene polymorphism and gastric cancer]. , 2007, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[40]  G. Perez-Perez,et al.  Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer , 2007, BMC Cancer.

[41]  S. Tsujitani,et al.  Distinct Recurrence Pattern and Outcome of Adenocarcinoma of the Gastric Cardia in Comparison with Carcinoma of Other Regions of the Stomach , 2006, World Journal of Surgery.

[42]  Christopher F. Martin,et al.  Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  E. Fontham,et al.  Interleukin-1β and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Gastric Cancer: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[44]  K. Lankarani,et al.  Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. , 2006, World journal of gastroenterology.

[45]  H. Yatsuya,et al.  Interleukin‐8 gene polymorphism associated with susceptibility to non‐cardia gastric carcinoma with microsatellite instability , 2006, Journal of gastroenterology and hepatology.

[46]  L. Hou,et al.  Interleukin-8 Polymorphisms Are Not Associated with Gastric Cancer Risk in a Polish Population , 2006, Cancer Epidemiology Biomarkers & Prevention.

[47]  R. R. Henry,et al.  Gastric cancer risk in a Mexican population: Role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin‐1 and ‐10 genes , 2006, International journal of cancer.

[48]  A. Hutchinson,et al.  Polymorphisms in Inflammation-related Genes and Risk of Gastric Cancer (Finland) , 2006, Cancer Causes & Control.

[49]  Ling Yang,et al.  Incidence and mortality of gastric cancer in China. , 2006, World journal of gastroenterology.

[50]  G. Perez-Perez,et al.  Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica , 2005, Clinical and Experimental Medicine.

[51]  Y. Hirooka,et al.  Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan , 2005, Cancer Epidemiology Biomarkers & Prevention.

[52]  F. Marincola,et al.  Interleukin‐10 and the immune response against cancer: a counterpoint , 2005, Journal of leukocyte biology.

[53]  Yi-ping Lin,et al.  The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese Population , 2005, Clinical Cancer Research.

[54]  Ammarin Thakkinstian,et al.  Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. , 2005, American journal of epidemiology.

[55]  Joon-Yong Park,et al.  Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. , 2005, Cancer letters.

[56]  Ammarin Thakkinstian,et al.  A method for meta‐analysis of molecular association studies , 2005, Statistics in medicine.

[57]  H. Lee,et al.  Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach , 2005, Cancer.

[58]  E. El-Omar,et al.  Role of the polymorphic IL‐1B, IL‐1RN and TNF‐A genes in distal gastric cancer in Mexico , 2005, International journal of cancer.

[59]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[60]  D. Lin,et al.  Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. , 2005, Carcinogenesis.

[61]  M. Rugge,et al.  Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. , 2005, Cytokine.

[62]  W. Guo,et al.  Interleukin-10 -1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China. , 2005, World journal of gastroenterology.

[63]  T. Koike,et al.  The polymorphism interleukin 8 −251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population , 2005, Gut.

[64]  S. Chanock,et al.  Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[65]  S. Chanock,et al.  Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[66]  Chien-Jen Chen,et al.  Interleukin‐10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese , 2003, International journal of cancer.

[67]  J. Goedert,et al.  Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. , 2003, Gastroenterology.

[68]  Leif E. Peterson,et al.  Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1β production in Helicobacter pylori infection , 2002 .

[69]  Yasuo Suzuki,et al.  Suppression of Helicobacter pylori‐induced interleukin‐8 production in gastric cancer cell lines by an anti‐ulcer drug, geranylgeranylacetone , 2002, Journal of gastroenterology and hepatology.

[70]  R. Eeles,et al.  Influence of cytokine gene polymorphisms on the development of prostate cancer. , 2002, Cancer research.

[71]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[72]  K. Chayama,et al.  Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas? , 2001, European journal of cancer.

[73]  D. Kwiatkowski,et al.  Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families , 2000, Thorax.

[74]  G. Catalano,et al.  Serum interleukin‐10 levels in patients with advanced gastrointestinal malignancies , 1999, Cancer.

[75]  I. Fidler,et al.  Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice , 1999, British Journal of Cancer.

[76]  H. Wanebo,et al.  Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck , 1997, Annals of Surgical Oncology.

[77]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[78]  A. Ben-Baruch,et al.  Signals and Receptors Involved in Recruitment of Inflammatory Cells (*) , 1995, The Journal of Biological Chemistry.

[79]  R. Rappuoli,et al.  Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. , 1995, Journal of clinical pathology.

[80]  D. Taub,et al.  Chemokines, inflammation and the immune system. , 1994, Therapeutic immunology.

[81]  C. O'Morain,et al.  Helicobacter pylori Infection , 1994 .

[82]  D. Dinsdale,et al.  Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria. , 1985, Carcinogenesis.

[83]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[84]  Xiaoting Wu,et al.  Interleukin-10 −1082 promoter polymorphism and gastric cancer risk in a Chinese Han population , 2010, Molecular and Cellular Biochemistry.

[85]  Peng Xiaowei The relationship among IL-10 gene polymorphisms,Helicobacter pylori and noncardia gastric cancer development in Fujian province , 2008 .

[86]  E. Fontham,et al.  Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. , 2006, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[87]  Hu Pin-jin Correlation of Polymorphism of Interleukin 8 Gene-251 Locus and Gastric Cancer in High and Low Prevalence Regions in China , 2005 .

[88]  W. Mellin,et al.  Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma , 2005, Journal of Cancer Research and Clinical Oncology.

[89]  Leif E. Peterson,et al.  Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. , 2002, Gastroenterology.

[90]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[91]  P. Subramaniam,et al.  Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle. , 1999, Blood.

[92]  P. Subramaniam,et al.  Mechanism of Interleukin-10 Inhibition of T-Helper Cell Activation by Superantigen at the Level of the Cell Cycle , 1999 .